Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Neuroprosthetics Market to Witness Augmented Demand Owing to High Prevalence Rate of Various Neurological Disorders Till 2024 | Million Insights


News provided by

Million Insights

02 Apr, 2018, 10:40 GMT

Share this article

Share toX

Share this article

Share toX

FELTON, California, April 2, 2018 /PRNewswire/ --

The Neuroprosthetics Market in 2015 was estimated at USD 4.2 billion globally. This can be attributed to high prevalence rate of disorders such as severe depression, Alzheimer's, muscle/neuromuscular junction disorder, ophthalmic, auditory, epilepsy, and Parkinson's which will drive the growth.

Also, the increasing investments in R&D for new products and device innovation & development for effective treatment plans to be used for neurological diseases are anticipated to provide significant boost to the overall demand. The increasing preference of self-charging devices, which uses bioenergy is expected to propel demand for brain implants throughout the forecast period. Furthermore, rise in aging population susceptible to neurological diseases is presumed to be a high impact factor for increasing neural implants demand throughout the forecast period.

Technology Insights 

The largest market share of around 50.0% was held by spinal cord stimulation segment in 2015. The dominant share can be attributed to high penetration of these devices with technological upgradations. These upgradations facilitate usage in various applications, to treat impaired autonomic, sensory, and motor functions.

Advent of technologically advanced products, that includes surgical implantable devices, featuring images, MRI, movable and automated probes, and local field potentials is predicted to provide attractive growth opportunities. Moreover, the frequent development of next-generation technologies by manufacturers, to enhance treatment interventions for restoration of impaired neurological functions, makes sacral nerve stimulators as fastest growing segment.

Browse 100 page research report with TOC on "Global Neuroprosthetics Market" at: https://www.millioninsights.com/industry-reports/neuroprosthetics-market 

Type Insights 

The largest market share was held by motor prosthetics followed by the cochlear prosthetics segment in 2015. The dominant share held by motor prosthetic can be attributed to increased adoption, preference for implantable devices in bladder control and brain computer interface for treatment of lateral sclerosis & paraplegic patients.

A rapid growth is seen by the auditory segment owing to the increase in usage of mid brain AMI's and brain stem implants ABI's by patients with impaired hearings. Cochlear implants can be used for stimulation therapy and signal processing systems, which is expected to broaden the treatment scope in the future for neural disorders.

Application Insights 

Traumatic brain injuries, spinal cord injuries, Parkinson's disease, and Alzheimer's can be treated with the use of neuroprosthetics. The neuroprosthetic devices can be broadly classified into cognitive & physiological disorders, and motor neuron abnormalities based on application. The largest application segment was found to be motor neuron disorders in 2015 owing to the increasing adoption in epilepsy and Parkinson's along with high prevalence of the aforementioned thereby leading to a widened consumer base.

The fastest growing segment is anticipated to be cognitive disorders as a consequence of rising prevalence of severe depression and Alzheimer's. Introduction of various technologically advanced stimulation devices which can stimulate motor controls and calculate limb trajectory to be used in paralysis treatment, is expected to further drive the market during the forecast period.

Regional Insights 

The largest share of over 50.0% in terms of revenue was held by North America in 2015. The dominancy in terms of revenue can be attributed to various factors such as, private and government funding as well as supportive healthcare infrastructure. Europe is anticipated to witness an upward shift as a consequence of advent of technologically advanced products for patients with impaired hearing and increasing initiatives by the government.

The fastest growing region is predicted to be Asia Pacific owing to the untapped opportunities present in this emerging region. The shifting focus towards overall cost containment in manufacturing of implants and high awareness amongst patients are predicted to drive the growth prospects. Moreover, increasing investments by the key players for development of new manufacturing facilities is expected to provide high growth potential over the coming years for neural implants.

Competitive Insights 

Various companies which offer solutions for a wide range of neurological disorders are BrainGate, Sonova, MED-EL, Nervo Corp., Retina Implant AG, St. Jude Medical Inc., and Boston Scientific Corporation. The prominent players include NeuroPace Inc, NDI Medical LLC, Medtronic Inc., Cyberonics Inc., and Cochlear Limited.

The oligopolistic nature of the market and companies help in providing technologically advanced and effective solutions including, stimulators, smart hearing devices, wireless mini microphones and advanced therapy for neurological diseases. Geographic expansion and strategic collaborations are some of the few sustainable strategies that are adopted by these players. This is predicted to keep the industry's competitive rivalry at the highest level and drive the market throughout the forecast period.

Browse more market research reports available with Million Insights: 

  • Chemiluminiscence Imaging Market 
  • Petrochemical Market 
  • Vaccine Market 
  • Intelligent Transportation System (ITS) Market 

Global Neuroprosthetics Type Outlook (Revenue, USD Million, 2013 - 2024) 

        • Motor Prosthetics

        • Auditory Prosthetics/Cochlear Implants

        • Cognitive Prosthetics

        • Visual Prosthetics/Retinal Implants

Global Neuroprosthetics Technology Outlook (Revenue, USD Million, 2013 - 2024) 

        • Deep Brain Stimulation (DBS)

        • Vagus Nerve Stimulation (VNS)

        • Spinal Cord Stimulation (SCS)

        • Sacral Nerve Stimulation (SNS)

Global Neuroprosthetics Application Outlook (Revenue, USD Million, 2013 - 2024) 

        • Motor Neuron Disorders

            • Parkinson's Disease

            • Epilepsy

        • Physiological Disorders

            • Auditory Processing Disorders

            • Ophthalmic Disorders

            • Cardiovascular Disorders

            • Kidney Diseases

        • Cognitive Disorders

            • Alzheimer's Disease

            • Severe Depression

Neuroprosthetics Regional Outlook (Revenue, USD Million, 2013 - 2024) 

        • North America

            • U.S.

            • Canada

        • Europe

            • UK

            • Germany

        • Asia Pacific

            • Japan

            • China

            • India

        • Latin America

            • Mexico

            • Brazil

        • MEA

            • South Africa

About Million Insights: 

Million Insights, is a distributor of market research reports, published by premium publishers only. We have a comprehensive market place, that will enable you to compare data points, before you make a purchase. Enabling informed buying, is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store, includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.

Contact:
Ryan Manuel
Research Support Specialist, USA
Million Insights
Phone: +1-408-610-2300
Toll Free: 1-866-831-4085
Email: sales@millioninsights.com

Web: https://www.millioninsights.com/

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.